CN Patent

CN117642157A — 具有((3-硝基苯基)磺酰基)乙酰胺作为bcl-2抑制剂的化合物

Assigned to Yier Therapeutics Co ltd · Expires 2024-03-01 · 2y expired

What this patent protects

本发明涉及一种BCL‑2蛋白的抑制剂化合物，其可用于治疗由所述酶调节的疾病和障碍，包括式(I)化合物：

USPTO Abstract

本发明涉及一种BCL‑2蛋白的抑制剂化合物，其可用于治疗由所述酶调节的疾病和障碍，包括式(I)化合物：

Drugs covered by this patent

Patent Metadata

Patent number
CN117642157A
Jurisdiction
CN
Classification
—
Expires
2024-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Yier Therapeutics Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.